4DMedical Limited (FDMDF) M&A Call Transcript
4DMedical Limited (FDMDF) Discusses Clinical Use of CT:VQ in Patient Selection for Lung Volume Reduction Surgery Transcript
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
4DMedical Limited (FDMDF) Discusses Imaging Technology Portfolio and Market Positioning in Cardio-Pulmonary Diagnostics Transcript
4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript
4DMedical Limited - Special Call
4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology